Endpoints News 2025-12-12 CHMP calls to reject Anavex's Alzheimer’s pill over impurities, side effects and weak efficacy
Endpoints News 2025-12-12 #SABCS25: Celcuity further details Phase 3 win; Relay’s PI3Kα inhibitor’s consistent performance; and more
Endpoints News 2025-12-12 Innovent’s obesity drug data in adolescents; Everest gets rights to PCSK9 inhibitor
Endpoints News 2025-12-12 FDA broadens label for Amgen's Uplizna as it enters rare disease competition
Endpoints News 2025-12-11 Top Trump lawyer calls on SCOTUS to reverse 'skinny' generic drug label decision
Endpoints News 2025-12-11 Rhythm reports Imcivree’s key weight loss data from Phase 2 Prader-Willi trial
Endpoints News 2025-12-11 AC Immune says early biomarker data are promising in Parkinson's, but clinical benefit remains unclear
Endpoints News 2025-12-11 Corbus’ obesity pill posts muted weight loss data; Disco adds another €16M in seed funding
Endpoints News 2025-12-11 Zealand inks deal with OTR Therapeutics as it spells out broader metabolic disease ambitions